Effectiveness of varied dose of pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C

被引：0
|
作者：
Midha, V. [1 ]
Sood, A. [1 ]
Hissar, S. S. [2 ]
Sood, N. [1 ]
Kumar, M. [2 ]
Sarin, S. K. [2 ]
机构：
[1] DMC, Dept Gastroenterol, Ludhiana, Punjab, India
[2] GB Pant Hosp, Dept Gastroenterol, New Delhi, India
来源：
PROCEEDINGS OF THE 16TH CONFERENCE OF THE ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER | 2006年
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1 / +
页数：2
相关论文
共 50 条
  • [31] Incidence of retinopathy in chronic Hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapy
    Kashif, Muhammad
    Saleem, Muhammad Khurram
    Farooka, Imran Khan
    Husnain, Amino
    Siddiqui, Arif Mahmood
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (01) : 174 - 177
  • [32] Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C
    Norio Horiike
    Morikazu Onji
    Journal of Gastroenterology, 2003, 38 : 302 - 304
  • [33] Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin
    Kaito, Masahiko
    Iwasa, Motoh
    Fujita, Naoki
    Kobayashi, Yoshinao
    Kojima, Yuji
    Ikoma, Jiro
    Imoto, Ichiro
    Adachi, Yukihiko
    Hamano, Hirokazu
    Yamauchi, Koji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (11) : 1894 - 1897
  • [34] Interferon α and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia
    Donada, C
    Crucitti, A
    Donadon, V
    Chemello, L
    Alberti, A
    BLOOD, 1998, 92 (08) : 2983 - 2984
  • [35] Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C
    Iwasaki, Y
    Ikeda, H
    Araki, Y
    Osawa, T
    Kita, K
    Ando, M
    Shimoe, T
    Takaguchi, K
    Hashimoto, N
    Kobatake, T
    Tomita, M
    Kawaguchi, M
    Kobashi, H
    Sakaguchi, K
    Shiratori, Y
    HEPATOLOGY, 2006, 43 (01) : 54 - 63
  • [36] Interferon-ribavirin combination therapy for chronic hepatitis C
    Schalm, SW
    Brouwer, JT
    Chemello, L
    Alberti, A
    Bellobuono, A
    Ideo, G
    Schwartz, R
    Weiland, O
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (12) : S131 - S134
  • [37] Retinol Supplements Antiviral Action of Pegylated Interferon and Ribavirin Combination Therapy in Patients With Chronic Hepatitis C: Prospective Pilot
    Sato, Shuichi
    Kohge, Naruaki
    Uchida, Yasushi
    Miyake, Tatsuya
    Tobita, Hiroshi
    Ishine, Junichi
    Hanaoka, Takuya
    Amano, Yuji
    Kinoshita, Yoshikazu
    GASTROENTEROLOGY, 2010, 138 (05) : S847 - S847
  • [38] The impact of thyroid autoantibodies on the treatment response to pegylated interferon plus ribavirin combination therapy in chronic hepatitis C patients
    Huang, C. K.
    Dai, C. Y.
    Huang, J. F.
    Hsieh, M. Y.
    Hou, N. J.
    Lin, W. Y.
    Lin, Z. Y.
    Chen, S. C.
    Wang, L. Y.
    Chuang, W. L.
    Yu, M. L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A187 - A187
  • [39] Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
    Tsugiko Oze
    Naoki Hiramatsu
    Takayuki Yakushijin
    Kiyoshi Mochizuki
    Masahide Oshita
    Hideki Hagiwara
    Eiji Mita
    Toshifumi Ito
    Yoshiaki Inui
    Hiroyuki Fukui
    Taizo Hijioka
    Kazuhiro Katayama
    Shinji Tamura
    Harumasa Yoshihara
    Atsuo Inoue
    Yasuharu Imai
    Eijiro Hayashi
    Michio Kato
    Atsushi Hosui
    Takuya Miyagi
    Hisashi Ishida
    Yuichi Yoshida
    Tomohide Tatsumi
    Shinichi Kiso
    Tatsuya Kanto
    Akinori Kasahara
    Tetsuo Takehara
    Norio Hayashi
    Journal of Gastroenterology, 2011, 46 : 1031 - 1037
  • [40] Studies of therapy with thymosin α1 in combination with pegylated interferon α2a and ribavirin in nonresponder patients with chronic hepatitis C
    Camerini, Roberto
    Ciancio, Alessia
    De Rosa, Alfonso
    Rizzetto, Mario
    THYMOSINS IN HEALTH AND DISEASE: FIRST INTERNATIONAL SYMPOSIUM, 2007, 1112 : 368 - 374
12345